The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 339:1247-1248 October 22, 1998 Number 17
NextNext

Merkel-Cell Carcinomas in Patients Treated with Methoxsalen and Ultraviolet A Radiation

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
To the Editor: Merkel-cell carcinoma is a very rare small-cell carcinoma of the skin.1 Probably derived from Merkel cells, the mechanoreceptors located in the basal layer of the epidermis, these tumors are asymptomatic, solitary, small red-purple subcutaneous nodules.2 Most are found in elderly persons at sites exposed to the sun. The two-year survival rate is about 50 percent.3 As is the case for non-melanoma skin cancers, especially squamous-cell cancers, exposure to ultraviolet radiation and, possibly, ionizing radiation are risk factors for Merkel-cell carcinoma.

Since 1975, we have prospectively studied 1380 patients with psoriasis who were treated with oral methoxsalen (psoralen) . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.